智通财经APP获悉，微创医疗(00853)午后涨近7%，截至发稿，涨5.4%，报8.2港元，成交额1.3亿港元。
消息面上，微创医疗发布年度业绩，2024年收入10.31亿美元，同比增长8.5%；公司权益股东应占亏损2.14亿美元，同比收窄55.2%；全年实现EBITDA转正，自去年亏损3.7亿美元改善至6040万美元。值得注意的是，公司各业务板块产品出海势头强劲，集团出海业务收入同比大幅增长85%。
美银证券发布研报称，通过严格执行成本控制措施，微创医疗实现了2024年净亏损低于2.75亿美元的目标。基于2024年的财报，计及新产品推出与带量采购政策的影响，将2025至2027年收入预测下调7%至8%，毛利率预测下调2至3个百分点，2025至2032年收入年均复合增长率长期预测则上调至14.4%。该行指，微创医疗海外市场增长潜力强劲，憧憬业务全球化可迅速推广。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.